Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Altorki

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
The Annals of Thoracic Surgery|December 4, 2013
Invited commentaryNasser Altorki
The Surgical Clinics of North America|June 2, 2005
En-bloc esophagectomy--the three-field dissectionNasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|July 29, 2021
Two-field lymph node dissection or three-field lymph node dissection. What's in a name?Nasser Altorki
The Annals of Thoracic Surgery|January 4, 2014
Invited commentaryNasser Altorki
The Journal of Surgical Research|March 12, 2004
COX-2: a target for prevention and treatment of esophageal cancerNasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|November 1, 2019
Commentary: High-dose induction chemoradiation for lung cancer: The past is prologueNasser Altorki, Brendon Stiles
Annals of Cardiothoracic Surgery|April 28, 2017
What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?Nasser Altorki, Sebron Harrison
Journal of Surgical Oncology|August 23, 2014
Outcomes in the management of esophageal cancerSubroto Paul, Nasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2020
Commentary: Can machine learning reduce readmissions after esophagectomy? A consummation devoutly to be wishedNasser Altorki, Art Sedrakyan
The Annals of Thoracic Surgery|June 6, 2015
Invited CommentaryBrendon Stiles, Nasser Altorki
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
The Annals of Thoracic Surgery|December 4, 2013
Invited commentaryNasser Altorki
The Surgical Clinics of North America|June 2, 2005
En-bloc esophagectomy--the three-field dissectionNasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|July 29, 2021
Two-field lymph node dissection or three-field lymph node dissection. What's in a name?Nasser Altorki
The Annals of Thoracic Surgery|January 4, 2014
Invited commentaryNasser Altorki
The Journal of Surgical Research|March 12, 2004
COX-2: a target for prevention and treatment of esophageal cancerNasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|November 1, 2019
Commentary: High-dose induction chemoradiation for lung cancer: The past is prologueNasser Altorki, Brendon Stiles
Annals of Cardiothoracic Surgery|April 28, 2017
What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?Nasser Altorki, Sebron Harrison
Journal of Surgical Oncology|August 23, 2014
Outcomes in the management of esophageal cancerSubroto Paul, Nasser Altorki
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2020
Commentary: Can machine learning reduce readmissions after esophagectomy? A consummation devoutly to be wishedNasser Altorki, Art Sedrakyan
The Annals of Thoracic Surgery|June 6, 2015
Invited CommentaryBrendon Stiles, Nasser Altorki
Pageof 10